Sakar Healthcare Ltd: remodeled- applied EU GMP, getting listed at Stock Exchange, becoming technorich with Lyophilizer

The goal of real healthcare reform must be high-quality, universal coverage in a cost-effective way. – Bernie Sanders

Playing a major role in revolutionizing the Healthcare industry, Pharmaceutical Companies are running hard to keep the pace with changing technology. New product launches and partnerships, agreements, and collaborations are the key strategies adopted by leading market players in the past three years to ensure their growth in the market. As a front runner in the race, Sakar Healthcare incorporated in the year 2004-05, is committed towards the improvement of the quality of human life by providing world-class healthcare services. Established by Sanjay Shah, an Entrepreneur with strategic foresight & excellent industry knowledge,

Sakar Healthcare is a leading manufacturer and marketer in the Global Pharmaceutical Industry. Envisioned to cater clients with the best of the services, the Company draws the future road map through technological enhancements. With an endeavor to cover regulated markets within 2 years, Sakar Healthcare has applied for necessary EU GMP approval aiming a turnover of 100 million USD in 5 years. Through the process of listing in stock exchange, Sakar Healthcare looks forward to strengthen their platform to operate globally.

Global presence
Sakar Healthcare has planned to reach out to 59 countries with around 500 brands including client products. In the process already 126 own brands have been registered to get marketed in 23 countries through strategic partnerships, rest being under process.

Valued Accreditations
Headquartered at Ahmedabad, Gujarat, India, Sakar Healthcare is an ISO 9001 BVQI certified company with state of art manufacturing units certified by WHO GMP, cGMP. The units are also approved by National Drug Authority of Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, MCA (Zimbabwe), Namibia, Nigeria & Cote D’Ivoire.

Exclusive Products Offered
Since its inception, the company has been engaged in manufacturing of pharmaceutical formulations which include

• Liquid Orals in pet and glass bottles
• Cephalosporin tablet, capsule, dry powder syrup and sachets
• Liquid Injectables (SVP) in ampoules and vials
• Dry powder injections (Cephalosporin)

The therapeutic categories include Analgesic, Anthelmintic, Anti-coagulants, Anti-malarial, Anti-spasmodic, Anti-anemic, Antibiotics, Anti-emetic, Anti-histamines, Bronchodilators, Corticosteroids, Cough and cold preparation, Multivitamin etc. The range also includes manufacturing of Alcohol/Codeine based products.

In their endeavor to deliver best to its clients, Sakar Healthcare offers best cost effective quality products to its customer base. Their dedicated facilities are designed as per the norms of MHRA and functioning involves latest technology and fully automatic machines.

Associations of value
Sakar Healthcare, as one of the most trusted & reliable Pharmaceutical manufacturer caters to the requirements of Pharmaceutical giants as well as markets own brands through its sales and distribution network. Their esteemed clientele base includes leaders of Indian Pharmaceutical industry like Zydus Cadila Healthcare Limited, Intas Pharmaceuticals Limited, Torrent Pharmaceuticals, IPCA Laboratories, Claris Lifesciences Ltd., Cadila Pharmaceuticals Ltd, Merck Ltd., BSV Ltd., Strides Acrolab, USV Ltd., Indoco Remedies Ltd., Cipla Ltd. Sakar Healthcare is well equipped to meet diversified requirements of clients for their export and domestic markets.

Adding Laurels to its Cap – Getting listed as Sakar Healthcare Ltd.
With a strong background in contract manufacturing and marketing brands overseas, Sakar Healthcare has set up a new milestone, with transformation of Sakar Healthcare Private Limited to Sakar Healthcare Limited this year. The procedures have been initiated to enlist in the stock exchange as well. This has not only enriched the background and credibility but has created the platform to attract more of business opportunities. The shift has given the required momentum to opt out for more of resources and create significant presence in previously untapped markets.

Venturing into Regulated markets: Applied EU GMP certification
Company has applied for EU GMP certificate to market brands in European Union. This would definitely enhance Sakar Healthcare’s market coverage.

Getting Technorich with Lyophilizer/ Freeze Dryer
Economic developments, rising shift of pharmaceutical and biotech industries from developed countries to Asia-Pacific and Latin American regions, growing investments of foreign freeze drying market players in these regions, and increasing private investments and venture funding to support new pharmaceutical product developments in these regions are the key factors driving the growth of the freeze drying market in developing regions. The lyophilizer would ensure benefits to esteemed clienteles both – domestic and international, therefore Sakar Healthcare has opted for this value added process of lyophilization to cater products which enhances stability and shelf life with ease in handling and transportation. This ensures increase in product basket offered and also plant more technologically rich.

These advancements have helped Sakar Healthcare to gear up and customize the services in recent years. With more of added values and efforts, Sakar Healthcare has recorded the maximum growth in recent time. With a vision- to become a global healthcare organization based on three pillars- people, partnership and performance making lives healthy, happy and more meaningful by providing world class healthcare solutions; stage is now well set for Sakar Healthcare to emerge globally as one of the top pharmaceutical companies from the Indian subcontinent.

“ Over the years, we have displayed a powerful drive for growth & advancement that are essentials for the varying circumstances in the Global Pharmaceutical Industry. We are committed, focused on our deliverables, loyal to our customers and innovative in our approaches.”